A 5-4 Supreme Court ruling on Monday limits product liability claims against the makers of generic drugs. A state law allowing the claims does not take precedence over federal laws that require generics to be the same and carry the same labeling as prescription drugs, Justice Samuel Alito wrote in the majority opinion.

Related Summaries